Nan Fung Group Holdings as of Sept. 30, 2023
Portfolio Holdings for Nan Fung Group Holdings
Nan Fung Group Holdings holds 39 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Karuna Therapeutics Ord | 30.9 | $38M | 226k | 169.09 | |
| Illumina (ILMN) | 13.3 | $16M | 119k | 137.28 | |
| Harmony Biosciences Hldgs In (HRMY) | 9.8 | $12M | 369k | 32.77 | |
| Seagen | 8.1 | $10M | 47k | 212.15 | |
| Oculis Holding Ordinary Shares (OCS) | 5.4 | $6.7M | 607k | 11.00 | |
| Somalogic Class A Com | 3.3 | $4.1M | 1.7M | 2.39 | |
| Exscientia Ads (EXAI) | 3.1 | $3.9M | 860k | 4.52 | |
| Xenon Pharmaceuticals (XENE) | 3.0 | $3.6M | 107k | 34.16 | |
| Merus N V (MRUS) | 2.6 | $3.2M | 137k | 23.58 | |
| Replimune Group (REPL) | 2.6 | $3.2M | 185k | 17.11 | |
| Kalvista Pharmaceuticals (KALV) | 1.8 | $2.3M | 235k | 9.63 | |
| Beigene Sponsored Adr (BGNE) | 1.8 | $2.2M | 12k | 179.87 | |
| Alpine Immune Sciences (ALPN) | 1.7 | $2.1M | 182k | 11.45 | |
| Incyte Corporation (INCY) | 1.5 | $1.8M | 32k | 57.77 | |
| Geron Corporation (GERN) | 1.3 | $1.6M | 754k | 2.12 | |
| Exelixis (EXEL) | 1.1 | $1.4M | 64k | 21.85 | |
| Bolt Biotherapeutics (BOLT) | 1.0 | $1.2M | 1.2M | 1.04 | |
| Pacific Biosciences of California (PACB) | 0.9 | $1.1M | 137k | 8.35 | |
| Rani Therapeutics Hldgs Com Cl A (RANI) | 0.9 | $1.1M | 494k | 2.17 | |
| Rhythm Pharmaceuticals (RYTM) | 0.7 | $919k | 40k | 22.93 | |
| Entrada Therapeutics (TRDA) | 0.6 | $776k | 49k | 15.80 | |
| Cabaletta Bio (CABA) | 0.6 | $718k | 47k | 15.22 | |
| Argenx Se Sponsored Adr (ARGX) | 0.6 | $703k | 1.4k | 491.63 | |
| Aerovate Therapeutics (AVTE) | 0.5 | $651k | 48k | 13.57 | |
| ACADIA Pharmaceuticals (ACAD) | 0.5 | $625k | 30k | 20.84 | |
| Biomea Fusion (BMEA) | 0.4 | $550k | 40k | 13.76 | |
| Dbv Technologies S A Sponsored Adr (DBVT) | 0.4 | $505k | 371k | 1.36 | |
| Athira Pharma (ATHA) | 0.3 | $364k | 180k | 2.02 | |
| Eargo Com New | 0.3 | $321k | 148k | 2.17 | |
| BioMarin Pharmaceutical (BMRN) | 0.3 | $320k | 3.6k | 88.48 | |
| Akero Therapeutics (AKRO) | 0.2 | $224k | 4.4k | 50.58 | |
| Alx Oncology Hldgs (ALXO) | 0.2 | $201k | 42k | 4.80 | |
| Affimed Therapeutics B V | 0.1 | $178k | 373k | 0.48 | |
| BioCryst Pharmaceuticals (BCRX) | 0.1 | $126k | 18k | 7.08 | |
| Galera Therapeutics (GRTX) | 0.1 | $107k | 613k | 0.18 | |
| Abcellera Biologics (ABCL) | 0.0 | $58k | 13k | 4.60 | |
| Fibrogen (FGEN) | 0.0 | $54k | 62k | 0.86 | |
| Kodiak Sciences (KOD) | 0.0 | $35k | 20k | 1.80 | |
| Cerus Corporation (CERS) | 0.0 | $23k | 14k | 1.62 |
